MCL1 and ovarian carcinoma: In conclusion, the effect of citrate on Mcl-1 expression could usefully be associated with inhibitors of Bcl-xL, since this strategy demonstrates a strong anti-cancer effect on chemoresistant ovarian cancer cells.